Scandinavian Medical Solutions AS (OCSE:SMSMED) ROE %: -25.74% (As of Mar. 2026)


OCSE:SMSMED Scandinavian Medical Solutions AS OCSE:SMSMED
81 GF Score
Price kr2.90
GF Value kr6.23
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Scandinavian Medical Solutions AS ROE %?

Scandinavian Medical Solutions AS OCSE:SMSMED -0.34% 81 ROE % is -25.74% as of Mar. 2026. GuruFocus rates OCSE:SMSMED with a GF Score™ of 81/100 and a GF Value™ of kr6.23 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Scandinavian Medical Solutions AS ranks worse than 66.5% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Scandinavian Medical Solutions AS's annualized net income for the quarter that ended in Mar. 2026 was kr-20.0 Mil. Scandinavian Medical Solutions AS's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was kr77.8 Mil. Therefore, Scandinavian Medical Solutions AS's annualized ROE % for the quarter that ended in Mar. 2026 was -25.74%.

The historical rank and industry rank for Scandinavian Medical Solutions AS's ROE % or its related term are showing as below:

OCSE:SMSMED' s ROE % Range Over the Past 10 Years
Min: -9.72   Med: 26.36   Max: 112.51
Current: -9.72

During the past 7 years, Scandinavian Medical Solutions AS's highest ROE % was 112.51%. The lowest was -9.72%. And the median was 26.36%.

OCSE:SMSMED's ROE % is ranked worse than
66.5% of 797 companies
in the Medical Devices & Instruments industry
Industry Median: 2.4 vs OCSE:SMSMED: -9.72

Scandinavian Medical Solutions AS  (OCSE:SMSMED) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-20.018/77.7555
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-20.018 / 184.586)*(184.586 / 201.2655)*(201.2655 / 77.7555)
=Net Margin %*Asset Turnover*Equity Multiplier
=-10.84 %*0.9171*2.5884
=ROA %*Equity Multiplier
=-9.94 %*2.5884
=-25.74 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-20.018/77.7555
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-20.018 / -26.14) * (-26.14 / -24.094) * (-24.094 / 184.586) * (184.586 / 201.2655) * (201.2655 / 77.7555)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7658 * 1.0849 * -13.05 % * 0.9171 * 2.5884
=-25.74 %

Note: The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Scandinavian Medical Solutions AS ROE % Related Terms


Scandinavian Medical Solutions AS ROE % Historical Data

* Premium members only.

The historical data trend for Scandinavian Medical Solutions AS's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scandinavian Medical Solutions AS ROE % Chart

Scandinavian Medical Solutions AS Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROE %
Get a 7-Day Free Trial 56.27 26.36 17.89 9.92 0.03

Scandinavian Medical Solutions AS Semi-Annual Data
Sep19 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.94 12.90 -5.75 5.81 -25.74

OCSE:SMSMED vs ABT, SYK, MDT: ROE % Comparison

For the Medical Devices subindustry, Scandinavian Medical Solutions AS's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scandinavian Medical Solutions AS ROE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Scandinavian Medical Solutions AS's ROE % distribution charts can be found below:

* The bar in red indicates where Scandinavian Medical Solutions AS's ROE % falls into.


OCSE:SMSMED
81GF Score
Scandinavian Medical Solutions AS OCSE:SMSMED
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scandinavian Medical Solutions AS ROE % Calculation

Scandinavian Medical Solutions AS's annualized ROE % for the fiscal year that ended in Sep. 2025 is calculated as

ROE %=Net Income (A: Sep. 2025 )/( (Total Stockholders Equity (A: Sep. 2024 )+Total Stockholders Equity (A: Sep. 2025 ))/ count )
=0.026/( (82.483+82.665)/ 2 )
=0.026/82.574
=0.03 %

Scandinavian Medical Solutions AS's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Sep. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-20.018/( (82.665+72.846)/ 2 )
=-20.018/77.7555
=-25.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -25.74% mean?
Scandinavian Medical Solutions AS (OCSE:SMSMED) has a ROE % of -25.74% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Scandinavian Medical Solutions AS and its competitors. According to the industry distribution chart, Scandinavian Medical Solutions AS ranks #530 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 66.5%.
Is Scandinavian Medical Solutions AS's ROE % too high?
Scandinavian Medical Solutions AS's current ROE % is -25.74%. Based on the distribution chart, Scandinavian Medical Solutions AS ranks #530 out of 797 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Scandinavian Medical Solutions AS has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Scandinavian Medical Solutions AS's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Scandinavian Medical Solutions AS ranks #530 out of 797 companies for ROE %. This places Scandinavian Medical Solutions AS in the lower half of its industry. The industry median ROE % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Scandinavian Medical Solutions AS and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scandinavian Medical Solutions AS's current ROE % is -25.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scandinavian Medical Solutions AS stock overvalued right now?
Based on GuruFocus' analysis, Scandinavian Medical Solutions AS (OCSE:SMSMED) is currently considered Possible Value Trap. The stock's GF Value™ is kr6.23, compared to a current price of kr2.90 — trading 53.5% below its estimated fair value. The current ROE % is -25.74%. Scandinavian Medical Solutions AS's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Scandinavian Medical Solutions AS (OCSE:SMSMED), the current ROE % is -25.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scandinavian Medical Solutions AS (OCSE:SMSMED) Overvalued in 2026?

Based on GuruFocus' analysis, Scandinavian Medical Solutions AS stock appears to be undervalued. The current stock price of kr2.90 is trading 53.5% below its estimated GF Value™ of kr6.23. GuruFocus considers Scandinavian Medical Solutions AS to be Possible Value Trap.

Key valuation signals for OCSE:SMSMED:

  • ROE %: -25.74%
  • GF Value™: kr6.23 vs. price of kr2.90 (53.5% below fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the OCSE:SMSMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scandinavian Medical Solutions AS Business Description

Other Exchanges K41:Germany
Address Gasvaerksvej 48, 1st Floor, Aalborg, DNK, 9000
Scandinavian Medical Solutions AS is a provider of Medical Imaging equipment. The company specializes in the acquisition, quality check, and resale of high-quality pre-owned medical imaging systems. The company supplies value-added resellers and distributors in various countries with MRI, CT, PET/CT, and other diagnostic scanners. It operates the business through three business areas, Equipment Solutions, Parts Solutions and Rental Solutions. Equipment Solutions is the company's main source of revenue, which focuses on sourcing, inspecting, and selling imaging systems such as MRI, CT, PET/CT, Cath-Lab, and Mammography units.
81GF Score

Get the complete analysis for OCSE:SMSMED

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.90
Price
kr6.23
GF Value